Clinical Study
Treatment of Prolactinomas in Low-Income Countries
Table 1
Characteristics of men and women with micro- and macroprolactinomas at diagnosis.
| | | Total | Microprolactinomas | Macroprolactinomas | |
| | Number (%) | 78 (100) | 38 (54.3) | 40 (45.7) | NA | | Pretreatment size (mm) | 6.5 (4.0–18.0) | 4.0 (3.0–6.0) | 26.0 (16.3–31.8) | <0.001 | | Men number (%) | 23 (100) | 0 (0) | 23 (100) | NA | | Women number (%) | 55 (100) | 38 (69.1) | 17 (30.9) | NA | | Age (years) | 40.0 (32.0–53.0) | 36.5 (32.000–50.0) | 43.0 (32.0–62.0) | 0.259 | | Serum prolactin levels (mcg/L) | 113.6 (60.5–941.5) | 63.5 (48.3–93.0) | 995.5 (417.0–2500.0) | <0.001 |
|
|
NA: not analyzed.
|
